Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bionano Genomics Inc (BNGO)

NASDAQ
Symbol
Exchange
Currency
BNGONASDAQUSD
0A4KLondonUSD
BNGOBIVAMXN
Currency in USD
Disclaimer
0.7861
+0.0271(+3.57%)
Closed
After Hours
0.7760-0.0101(-1.2848%)

BNGO Price Commentary

I have bought more shares during the dip. Now 7250.
👏👏👏
https://www.reddit.com/r/BNGO/comments/lxurn9/has_bngo_doubled_its_revenue_in_q4/?utm_medium=android_app&utm_source=share
Im letting mine run, as the whole market is in freefall. I expect institutional buying at this and possibly lower levels, so pretty relaxed.For anyone checking daily, i’d suggest stopping and come back at the end of the month.
I was sitting watching the 1 day chart and price and irs depressing. I think the company is strong, so i expect it to come back. Im happu to let it run for 5 years.
Thanks for the advice. I must admit, watching my Bionano, Nio and others plummer is a hard watch. I keep trying not to look, but it's not that easy. I'm really hoping you (and Pepe) are correct. Big girl pants required!
you just wait. My time horizon is 5 years. It will be a lot higher then. Great investment.
rebought at 6.95
I havent sold. I will need the money in 10 years. Let’s see where we are at in 10 years.
Ooft
eject, eject!! lol
wow another 10% down today
When will it stop going down ?
its ******cheap now, i loaded up at 8.60
Everyone sold out to jump on the TRXC and OCGN bandwagon!
trxc is making moves
Slightly worried now
me too! whats going on?
 Not sure, I know the whole market is down, but there is just no volume here. I'm hoping the price is reduced to account for Q4 results, which I wouldnt expect to be great, but the forecast should be much better!
I the Nasdaq is coming back down to 1200ish
Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr
march 3, 2021 https://ir.bionanogenomics.com/
March 2, 2021 8:22 AMBionano Genomics to Present at the Cowen 41st Annual Health Care Conference
https://ir.bionanogenomics.com/
No BUY here. SELL! SELL! SELL!
You keep that long, and prepare to wait for longer....by the way, my sentiment is based on short term trading.
no one sells on dip💅go sell gme
 Not another one!
Everything this company is doing makes sense. First brand recognition. Then more sales. I am sure the earnings will be good.
is it good time to buy???
I love this company! I have 3,000 shares with an average of $7.50 each and will hold until triple figures
vanguard bought 1.45 million more shares in bngo
it isnt showing average price for me they have locked in free version..anyways positive thing is that they are holding such amounts of shares, whole media talks about it also and it's very good
 Oh I agree, it is great news, but it doesnt look like a recent purchase. you can work out the buy price, by taking the amount of shares and dividing by the cost, which I worked out at around $3.10 per share. They wouldnt have been able to buy at that price now, so it must have been during one of the offerings, probably the first.
thanks😊
Bionano to be Featured at AGBT 2021 with Presentations of Scientific Discoveries made with Saphyr in Psychiatric Disorders and CancerSAN DIEGO, March 01, 2021
https://ir.bionanogenomics.com/single-news-releases?storyid=6252306995556583
The University Health Network's Laboratory Medicine Program in Toronto is piloting the Saphyr system from Bionano Genomics. If this is successful (and there is no reason to not be successful), then the sky is the limit.
hope so Pepe!
Imagine if it reached $200 per share in the next 5 years.... i can retire and go fishing most days!! :)
Thats the dream, Pepe. I think things shouldnt be as grim this week.
on official nasdaq website, article got published, where bngo is in top 4 health care stock for march 2021🚀
https://www.nasdaq.com/articles/are-these-top-health-care-stocks-worth-watching-ahead-of-march-2021-02-25
Great info, thanks
Praxis Genomics has received Z codes for all tests based on Bionano Optical Genome Mapping (OGM) and Illumina Short Read (ISR) whole genome analysis.
Bionano Genomics will be attending oppenheimer’s 31st Annual Healthcare Conference, March 16-18, 2021
I agree Pepe
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.